A new drug for advanced solid tumors that have stopped responding to treatment
Part of Cancer clinical trials.
This study tests a new medication for people with advanced solid tumors that have not responded to standard treatments or for whom no good standard treatment exists. The drug targets a protein called SSEA-4 that may be present on cancer cells, potentially slowing or stopping their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a type of cancer that has spread or cannot be removed with surgery.
- You must have tried standard treatments, or your doctor says they won't help, or you chose not to have them.
- You need to have a tumor sample (from a biopsy or surgery) available for testing.
- Your organs (like liver, kidneys, and blood counts) must be working well enough.
- You must be willing to use effective birth control if you or your partner can have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug that may help people with advanced solid tumors, including liver, stomach, and brain cancers. It is for patients whose cancer has not responded to standard treatments or who cannot have them. The study aims to find the right dose and check safety and effectiveness.
This study tests a new experimental drug (called SYS6051) in people with advanced solid tumors that have not responded to standard treatments. The goal is to find out if the drug is safe and how well it works, and it might help control your cancer.
This trial tests a new oral drug (DAT-1604) for people with advanced solid tumors that have stopped responding to other treatments. The goal is to see if it is safe, how the body processes it, and whether it can shrink or slow tumor growth.
This trial tests a new drug called SOA101 for people with certain advanced cancers that have stopped responding to standard treatments. It aims to see if the drug is safe and if it can help shrink tumors.
This trial tests a new drug, SSS59, in people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and how it affects the body.
This trial tests a new drug called SMP-3124LP for people with advanced solid tumors that no longer respond to standard treatments. It is given in two phases: first to find the best dose (dose escalation) and then to see how well it works in specific cancer types (dose expansion).
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.